Joshua Brody, Director of the Lymphoma Immunotherapy Program at Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Quick basics on Lymphoma Immunotherapy how they work and how they fail in plain-speak:
Overcoming Resistance in Lymphoma With Targeted Immunotherapies
And how our lab Mount Sinai NYC is working on fixes.”
Other articles about Immunotherapy on OncoDaily.